CliffBio
small molecule

AMOXICILLIN AND CLAVULANATE POTASSIUM

AMOXICILLIN; CLAVULANATE POTASSIUM

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameAMOXICILLIN AND CLAVULANATE POTASSIUM
Active ingredientAMOXICILLIN; CLAVULANATE POTASSIUM
Strength250MG/5ML;EQ 62.5MG BASE/5ML
Dosage formFOR SUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2008
Marketing statusRX

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

AMOXICILLIN AND CLAVULANATE POTASSIUM patent cliff — loss of exclusivity — | CliffBio